Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice.

Autor: Sligar, Chloe1,2, Reilly, Ellie1,2, Cuthbertson, Peter1,2, Vine, Kara L1,2, Bird, Katrina M1,2, Elhage, Amal1,2, Alexander, Stephen I3, Sluyter, Ronald1,2 rsluyter@uow.edu.au, Watson, Debbie1,2 dwatson@uow.edu.au
Zdroj: Clinical & Translational Immunology. 2024, Vol. 13 Issue 3, p1-19. 19p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje